TransMedics Group Q3 2026 Results: Net Income $17.1M, Down 29.8% YoY
TransMedics Group reported total revenue of $203.0 million for the third quarter of 2026, a 41% increase year-over-year, driven by growth in both product and service revenue. Net income for the quarter was $17.1 million, down from $24.3 million in the prior year period, primarily due to increased operating expenses in research, development, and clinical trials.
- Key figure
- Net income $17.1M · -29.8% YoY